Literature DB >> 2860944

Antisecretory drugs and gastric cancer.

M J Langman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2860944      PMCID： PMC1416806          DOI： 10.1136/bmj.290.6485.1850

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  19 in total

1.  Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride.

Authors:  G R Betton; G K Salmon
Journal:  Scand J Gastroenterol Suppl       Date:  1984

2.  Gastric cancer after cimetidine in patient with two negative pre-treatment biopsies.

Authors:  P C Hawker; T J Muscroft; M R Keighley
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

3.  Intragastric N-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer.

Authors:  M R Keighley; D Youngs; V Poxon; D Morris; T J Muscroft; D W Burdon; J Barnard; P M Bavin; R W Brimblecombe; D W Darkin
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

4.  Pernicious anemia and the development of carcinoid tumors of the stomach.

Authors:  A I Harris; H Greenberg
Journal:  JAMA       Date:  1978-03-20       Impact factor: 56.272

5.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.

Authors:  B K Sharma; I A Santana; E C Wood; R P Walt; M Pereira; P Noone; P L Smith; C L Walters; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

6.  Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin.

Authors:  L I Larsson; J F Rehfeld; R Stockbrügger; G Blohme; I M Schöön; G Lundqvist; L G Kindblom; J Säve-Söderberg; L Grimelius; L Olbe
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

7.  The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy.

Authors:  J A Carney; V L Go; V F Fairbanks; S B Moore; E C Alport; F E Nora
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

8.  Pathologic findings in the stomachs of rats treated with the H2-receptor antagonist tiotidine.

Authors:  C S Streett; R E Cimprich; J L Robertson
Journal:  Scand J Gastroenterol Suppl       Date:  1984

9.  Cimetidine and gastric cancer.

Authors:  J B Elder; P C Ganguli; I E Gillespie
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

10.  Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.

Authors:  C T Richardson; M Feldman; C Brater; J Welborn
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682
View more
  14 in total

Review 1.  There is more to healing ulcers than suppressing acid.

Authors:  D G Colin-Jones
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

Review 2.  Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Authors:  Jeong Soo Ahn; Chun-Sick Eom; Christie Y Jeon; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

3.  The antisecretory effects of zaltidine, a novel long-acting H2-receptor antagonist, in healthy volunteers and in subjects with a past history of duodenal ulcer.

Authors:  G Laferla; N Buchanan; J Hearns; G P Crean; K E McColl; A T Clucas
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 4.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 5.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

6.  Cancer occurrence in a cohort of patients treated with cimetidine.

Authors:  H Møller; K Lindvig; R Klefter; J Mosbech; O Møller Jensen
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

Review 7.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

8.  Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.

Authors:  H Møller; A Nissen; J Mosbech
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.

Authors:  K Lauritsen; S J Rune; H R Wulff; J H Olsen; L S Laursen; T Havelund; L Astrup; F Bendtsen; J Linde; P Bytzer
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

Review 10.  Gastroesophageal reflux: clinical presentations, diagnosis and management.

Authors:  W E Waterfall; M A Craven; C J Allen
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.